Potential rebreathing of carbon dioxide during noninvasive ventilation provided by critical care ventilator.
CO2rebreathing
carbon dioxide clearance
full-face mask
mechanical ventilation
noninvasive ventilation
oronasal mask
Journal
Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR
ISSN: 1205-9838
Titre abrégé: Can J Respir Ther
Pays: Canada
ID NLM: 9617402
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
11
8
2022
pubmed:
12
8
2022
medline:
12
8
2022
Statut:
epublish
Résumé
Critical care ventilators are frequently used to provide noninvasive ventilation (NIV) support to critically ill patients. Questions remain regarding carbon dioxide (CO This randomized crossover trial was conducted at an academic medical center in the Midwest United States. After obtaining informed consent, eight healthy volunteers were placed on a 980 Puritan Bennett (Medtronic, Minneapolis, MN) ventilator operating in the NIV mode. All subjects performed 20 min of breathing on four levels of PEEP (0, 2, 4, and 5 cm H Median (IQR) A PEEP level of at least 5 cm H
Sections du résumé
Background
UNASSIGNED
Critical care ventilators are frequently used to provide noninvasive ventilation (NIV) support to critically ill patients. Questions remain regarding carbon dioxide (CO
Method
UNASSIGNED
This randomized crossover trial was conducted at an academic medical center in the Midwest United States. After obtaining informed consent, eight healthy volunteers were placed on a 980 Puritan Bennett (Medtronic, Minneapolis, MN) ventilator operating in the NIV mode. All subjects performed 20 min of breathing on four levels of PEEP (0, 2, 4, and 5 cm H
Results
UNASSIGNED
Median (IQR)
Conclusion
UNASSIGNED
A PEEP level of at least 5 cm H
Identifiants
pubmed: 35950170
doi: 10.29390/cjrt-2022-013
pii: 013
pmc: PMC9328670
doi:
Types de publication
Journal Article
Langues
eng
Pagination
111-114Déclaration de conflit d'intérêts
All authors have completed the ICJME uniform disclosure form at http://www.icmje.org/disclosure-of-interest/ and declare: Mr. Al Hussain has no conflict of interest. Dr. Vines reports speaking for Theravance Biopharma and research funding from Teleflex Medical, Inc. and Rice Foundation.
Références
J Bras Pneumol. 2009 Feb;35(2):164-73
pubmed: 19287920
Eur Respir J. 2015 Mar;45(3):691-9
pubmed: 25504992
Ann Transl Med. 2018 Sep;6(18):355
pubmed: 30370282
Cochrane Database Syst Rev. 2017 Jul 13;7:CD004104
pubmed: 28702957
Monaldi Arch Chest Dis. 2008 Sep;69(3):114-8
pubmed: 19065845
Can Respir J. 2017;2017:2048032
pubmed: 28270737
Crit Care. 2013 Nov 11;17(6):R269
pubmed: 24215648
Respir Care. 2021 Jan;66(1):25-32
pubmed: 32962995
J Bras Pneumol. 2014 May-Jun;40(3):294-303
pubmed: 25029653
Minerva Anestesiol. 2015 May;81(5):526-32
pubmed: 25317575
Eur Respir J. 2017 Aug 31;50(2):
pubmed: 28860265
Chest. 1995 Sep;108(3):772-8
pubmed: 7656632